Jane Street
CGEM icon

Jane Street’s Cullinan Oncology CGEM Stock Holding History

Jane Street’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,812
Closed -$339K – 11683
2026
Q1 		$324K Sell
22,812
-164,032
-88% -$2.11M ﹤0.01% 9066
2025
Q4 		$1.93M Sell
186,844
-114,041
-38% -$1.03M ﹤0.01% 4883
2025
Q3 		$1.78M Buy
300,885
+252,002
+516% +$1.85M ﹤0.01% 5154
2025
Q2 		$368K Buy
48,883
+14,487
+42% +$116K ﹤0.01% 7484
2025
Q1 		$260K Buy
34,396
+19,813
+136% +$190K ﹤0.01% 8037
2024
Q4 		$178K Sell
14,583
-6,572
-31% -$94.5K ﹤0.01% 8490
2024
Q3 		$354K Sell
21,155
-75,441
-78% -$1.34M ﹤0.01% 7762
2024
Q2 		$1.68M Buy
96,596
+75,592
+360% +$1.61M ﹤0.01% 4799
2024
Q1 		$358K Buy
21,004
+7,202
+52% +$111K ﹤0.01% 7276
2023
Q4 		$141K Sell
13,802
-2,812
-17% -$24.9K ﹤0.01% 8427
2023
Q3 		$150K Sell
16,614
-37,269
-69% -$388K ﹤0.01% 7786
2023
Q2 		$580K Buy
53,883
+32,196
+148% +$342K ﹤0.01% 6091
2023
Q1 		$222K Buy
+21,687
New +$239K ﹤0.01% 7695

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jane Street's CGEM Position: Q2 2026 in Review

Jane Street sold out of Cullinan Oncology (CGEM) in Q2 2026, closing a stake of 22,812 shares — an estimated $339K sold.

Jane Street first reported a position in CGEM in Q1 2023 and held it in 13 quarters. The position peaked at $1.93M in Q4 2025. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Jane Street reported no remaining Cullinan Oncology position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 22,812 Cullinan Oncology shares in Q2 2026, an estimated $339K.
  • Jane Street first reported a position in Cullinan Oncology in Q1 2023 and held it in 13 quarters.
  • Jane Street's Cullinan Oncology position peaked at $1.93M in Q4 2025.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.